XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,128,000 | +0.6% | 460,500 | +67.2% | 0.17% | +10.4% |
Q2 2021 | $1,121,000 | -58.0% | 275,500 | -53.4% | 0.15% | -61.2% |
Q1 2021 | $2,666,000 | -21.9% | 591,088 | -14.8% | 0.40% | -24.1% |
Q4 2020 | $3,414,000 | -32.5% | 693,870 | -18.7% | 0.52% | -42.2% |
Q3 2020 | $5,059,000 | +639.6% | 853,132 | +231.8% | 0.90% | +532.9% |
Q2 2020 | $684,000 | – | 257,132 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
SEARLE & CO. | 34,000 | $167,000 | 0.08% |
GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |